Huntington's Flashcards

1
Q

What is Huntington’s disease

A

Degeneration of the striatum and later cortex and other areas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the clinical signs of Huntington’s disease - motor symptoms

A

Chorea: Involuntary, jerky, and uncoordinated movements.

Dystonia: Sustained or repetitive muscle contractions causing abnormal postures or movements.

Bradykinesia: Slowed voluntary movement.

Rigidity: Stiffness in muscles.

Impaired balance and coordination, leading to frequent falls.

Difficulty swallowing (dysphagia) and speech impairments (dysarthria).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the clinical signs of Huntington’s disease - cognitive symptoms

A

Memory impairments: Difficulty recalling information or learning new things.

Reduced ability to plan and organize: Challenges with executive functioning.

Difficulty concentrating and short attention span.

Impaired judgment and decision-making abilities.

Progressive dementia in later stages.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the clinical signs of Huntington’s disease - psychiatric symptoms

A

Depression: Persistent sadness, lack of motivation, and suicidal thoughts.

Irritability and mood swings.

Obsessive-compulsive behaviours: Repeated, intrusive thoughts and ritualistic actions.

Anxiety disorders.

Psychosis: Rare, but may involve hallucinations or delusions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the clinical signs of Huntington’s disease - other features

A

Sleep disturbances.

Weight loss: Despite adequate or increased food intake, due to metabolic and physical challenges.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the purpose of palliative treatment

A

Palliative treatment focuses on:
- relieving symptoms,
- improving quality of life, and
- addressing the emotional, psychological, and social needs of patients with chronic or incurable conditions.

Unlike curative treatments, palliative care does not aim to cure the underlying disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the options for palliative treatment in HD

A

Physical therapy
- Swallowing
- Involuntary movements
- Cognition

Tetrabenazine (dopamine reducing agent)
- Involuntary movements

Selective serotonin reuptake inhibitors + cognitive behavioural therapy
- depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What type of disease is Huntington’s and what causes it genetically

A

Monogenic disease

Expansion of a CAG/CTG repeat in the Huntingtin gene

Caused by multiple molecular mechanisms
- Tackling any one of them individually is not going to be enough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the main modifiers of the severity of the disease

A

Repeat size
- Motor and neurological symptoms correlate with repeat size

Somatic expansion - measured with small-pool PCR
- Genome wide association finds genes that modify disease severity
- Most loci are genes involved in mismatch repair, which changes the rates of somatic expansions
- Removing mismatch repair improves molecular signs of HD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the 3 types of ATMPs (advanced therapy medicinal products)

A
  1. Cell therapy
    • These contain cells or tissues that have been manipulated to change their biological characteristics or cells or tissues not intended to be used for the same essential functions in the body
  2. Gene therapy
    • They work by inserting ‘recombinant’ genes into the body, usually to treat a variety of diseases, including genetic disorders, cancer or long-term diseases
    • A recombinant gene is a stretch of DNA that is created in the laboratory, bringing together DNA from different sources
  3. Tissue engineering
    • These contain cells or tissues that have been modified so they can be used to repair, regenerate or replace human tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the 3 forms of gene therapy

A

Supplementation - e.g. overexpressing a gene that is missing

Downregulation - e.g. silencing a faulty gene

Gene editing - e.g. mutate or correct a faulty gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What kind of inheritance leads to what type of mutation

A

Recessive
- Loss of function

Dominant
- Haploinsufficient
- Dominant negative
- Gain of function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a recessive mutation

A

Recessive if one copy of the protein is enough for normal activity

When this is not the case, then the mutations are dominant and this is called haploinsufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are gain of function mutations

A

Mutant protein has a new toxic function in addition to the normal function but it retains the normal function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are dominant negative mutations

A

The mutant protein interferes with the function of the normal protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What type of ATMP can be used to treat each mutation type

A

Supplementation
- Recessive
- Haploinsufficient
- Dominant negative

Downregulation
- Dominant negative
- Toxic gain of function

Gene editing
- Dominant negative
- Toxic gain of function

17
Q

How do you show that a gene is haploinsufficient

A

Prediction: heterozygotes knockout mice will develop the disease

They do not -> disease is not haploinsufficient

18
Q

How to show that it is a gain of function mutation

A

Prediction: adding the mutation to a mouse would cause the disease

Mouse gains the disease and retains its normal function but also acquires a harmful new activity.

Cellular assays can be used to show abnormal interactions or toxic effects unique to the mutant protein

19
Q

What are some examples of ATMPs for Huntington’s disease

A

Zinc Finger Transcriptional Repressors: Suppress mutant huntingtin (mHTT) gene expression.

CRISPR/Cas9 Gene Editing: Specifically targets and edits the expanded CAG repeats in the HTT gene.
- CRISPR/Cas9 + allele - specific SNP
- CRISPR/Cas9 to introduce DNA break

Antisense Oligonucleotides (ASOs): Bind to mRNA to reduce mutant huntingtin protein production.

RNA Interference (RNAi): Silences the mHTT gene by degrading its RNA transcripts.

Stem Cell Therapy: Replaces damaged neurons and supports neuroprotection.

Gene Therapy via Viral Vectors: Delivers therapeutic genes to modify or reduce mHTT expression.

Small molecules to disrupt pre-mRNA splicing

20
Q

What are the cellular consequences of mHTT presence

A

Transcriptional dysregulation

Dysregulation proteosome and autophagy systems

Disruption of BDNF-mediated functions

Mitochondrial dysfunction

Endoplasmic reticulum stress

Excitotoxicity

Synaptic dysfunction

Cholesterol metabolism

21
Q

What are the 3 main challenges of gene editing

A

Efficiency

Delivery

Safety

22
Q

What is the main gene editing treatment in HD and how does it work

A

CRISPR/Cas9 nickase for the treatment of HD

Targeting the Mutant Allele: The nickase is engineered to specifically recognize and bind the expanded CAG repeat in the mutant HTT gene.

Creating a Single-Strand Break: Instead of cutting both DNA strands, the nickase makes a precise nick (single-strand cut) at the target site.

Promoting Repair or Contraction: The cell’s repair mechanisms are triggered, leading to the contraction of the expanded CAG repeat in the mutant allele while sparing the normal allele